
Oral Transmucosal Drugs Global Market Report 2025
Description
Oral Transmucosal Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on oral transmucosal drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for oral transmucosal drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral transmucosal drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product Type: Tablets; Films; Liquid And Spray; Other Product Types
2) By Indication: Opioid Dependence; Nausea And Vomiting; Erectile Dysfunction; Neurological Disorders; Other Indications
3) By Route Of Administration: Sublingual Mucosa; Buccal Mucosa; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Tablets: Buccal Tablets; Sublingual Tablets; Effervescent Tablets
2) By Films: Buccal Films; Sublingual Films; Mucoadhesive Films
3) By Liquid And Spray: Sublingual Liquid Solutions; Oral Sprays (Pain Relief, Sleep Aids); Mucosal Gels
4) By Other Product Types: Lozenges; Pastilles; Chewing Gums
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Sanofi-Aventis LLC; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on oral transmucosal drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for oral transmucosal drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral transmucosal drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product Type: Tablets; Films; Liquid And Spray; Other Product Types
2) By Indication: Opioid Dependence; Nausea And Vomiting; Erectile Dysfunction; Neurological Disorders; Other Indications
3) By Route Of Administration: Sublingual Mucosa; Buccal Mucosa; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Tablets: Buccal Tablets; Sublingual Tablets; Effervescent Tablets
2) By Films: Buccal Films; Sublingual Films; Mucoadhesive Films
3) By Liquid And Spray: Sublingual Liquid Solutions; Oral Sprays (Pain Relief, Sleep Aids); Mucosal Gels
4) By Other Product Types: Lozenges; Pastilles; Chewing Gums
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Sanofi-Aventis LLC; AstraZeneca PLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Oral Transmucosal Drugs Market Characteristics
- 3. Oral Transmucosal Drugs Market Trends And Strategies
- 4. Oral Transmucosal Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Oral Transmucosal Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Oral Transmucosal Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Oral Transmucosal Drugs Market Growth Rate Analysis
- 5.4. Global Oral Transmucosal Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Oral Transmucosal Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Oral Transmucosal Drugs Total Addressable Market (TAM)
- 6. Oral Transmucosal Drugs Market Segmentation
- 6.1. Global Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Films
- Liquid And Spray
- Other Product Types
- 6.2. Global Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Opioid Dependence
- Nausea And Vomiting
- Erectile Dysfunction
- Neurological Disorders
- Other Indications
- 6.3. Global Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sublingual Mucosa
- Buccal Mucosa
- Other Routes Of Administration
- 6.4. Global Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Buccal Tablets
- Sublingual Tablets
- Effervescent Tablets
- 6.6. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Films, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Buccal Films
- Sublingual Films
- Mucoadhesive Films
- 6.7. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Liquid And Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sublingual Liquid Solutions
- Oral Sprays (Pain Relief, Sleep Aids)
- Mucosal Gels
- 6.8. Global Oral Transmucosal Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lozenges
- Pastilles
- Chewing Gums
- 7. Oral Transmucosal Drugs Market Regional And Country Analysis
- 7.1. Global Oral Transmucosal Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Oral Transmucosal Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Oral Transmucosal Drugs Market
- 8.1. Asia-Pacific Oral Transmucosal Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Oral Transmucosal Drugs Market
- 9.1. China Oral Transmucosal Drugs Market Overview
- 9.2. China Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Oral Transmucosal Drugs Market
- 10.1. India Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Oral Transmucosal Drugs Market
- 11.1. Japan Oral Transmucosal Drugs Market Overview
- 11.2. Japan Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Oral Transmucosal Drugs Market
- 12.1. Australia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Oral Transmucosal Drugs Market
- 13.1. Indonesia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Oral Transmucosal Drugs Market
- 14.1. South Korea Oral Transmucosal Drugs Market Overview
- 14.2. South Korea Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Oral Transmucosal Drugs Market
- 15.1. Western Europe Oral Transmucosal Drugs Market Overview
- 15.2. Western Europe Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Oral Transmucosal Drugs Market
- 16.1. UK Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Oral Transmucosal Drugs Market
- 17.1. Germany Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Oral Transmucosal Drugs Market
- 18.1. France Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Oral Transmucosal Drugs Market
- 19.1. Italy Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Oral Transmucosal Drugs Market
- 20.1. Spain Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Oral Transmucosal Drugs Market
- 21.1. Eastern Europe Oral Transmucosal Drugs Market Overview
- 21.2. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Oral Transmucosal Drugs Market
- 22.1. Russia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Oral Transmucosal Drugs Market
- 23.1. North America Oral Transmucosal Drugs Market Overview
- 23.2. North America Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Oral Transmucosal Drugs Market
- 24.1. USA Oral Transmucosal Drugs Market Overview
- 24.2. USA Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Oral Transmucosal Drugs Market
- 25.1. Canada Oral Transmucosal Drugs Market Overview
- 25.2. Canada Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Oral Transmucosal Drugs Market
- 26.1. South America Oral Transmucosal Drugs Market Overview
- 26.2. South America Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Oral Transmucosal Drugs Market
- 27.1. Brazil Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Oral Transmucosal Drugs Market
- 28.1. Middle East Oral Transmucosal Drugs Market Overview
- 28.2. Middle East Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Oral Transmucosal Drugs Market
- 29.1. Africa Oral Transmucosal Drugs Market Overview
- 29.2. Africa Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Oral Transmucosal Drugs Market Competitive Landscape And Company Profiles
- 30.1. Oral Transmucosal Drugs Market Competitive Landscape
- 30.2. Oral Transmucosal Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 31. Oral Transmucosal Drugs Market Other Major And Innovative Companies
- 31.1. Abbott Laboratories
- 31.2. Novartis AG
- 31.3. GlaxoSmithKline plc
- 31.4. Eli Lilly & Company Ltd.
- 31.5. Boehringer Ingelheim International GmbH
- 31.6. Viatris Inc.
- 31.7. Teva Pharmaceutical Industries Ltd.
- 31.8. Biogen Inc.
- 31.9. Actavis Pharma Inc.
- 31.10. Sun Pharmaceutical Industries Limited
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Endo Pharmaceuticals Inc.
- 31.13. Lupin Limited
- 31.14. Zydus Lifesciences Limited
- 31.15. Mallinckrodt Pharmaceuticals Plc
- 32. Global Oral Transmucosal Drugs Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Oral Transmucosal Drugs Market
- 34. Recent Developments In The Oral Transmucosal Drugs Market
- 35. Oral Transmucosal Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Oral Transmucosal Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Oral Transmucosal Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Oral Transmucosal Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.